3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Lung Neoplasms
2
Breast Neoplasms
2
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Propofol
6
Carboplatin
5
Sevoflurane
4
Saline Solution
3
Paclitaxel
3
Nivolumab
3
Erlotinib Hydrochloride
3
Acetaminophen
3
Pemetrexed
2
Midazolam
2
Lidocaine
2
Isoflurane
2
Docetaxel
2
Desflurane
2
Cryotherapy
2
Bupivacaine
2
Bronchoscopy
2
Anesthesia, Inhalation
2
trametinib
1
sotorasib
1
pegfilgrastim
1
icotinib
1
endostar protein
1
durvalumab
1
dabrafenib
1
capmatinib
1
camrelizumab
1
beta Carotene
1
atezolizumab
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Lung Neoplasms
×
Isoflurane
×
Clear all
NCT06330038
2026-04-20
GASTIVA
Samsung Medical Center
Phase 4
Recruiting
5,384 enrolled
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled